On October 30, the Technical Exchange Meeting on High-Quality Development and Digital Empowerment of Traditional Chinese Medicine Enterprises was held in Shenzhen. The meeting was hosted by the Precision Medicine Research Center of the Shenzhen Institute of Metrology and Quality Inspection (Shenzhen Shenjian Group Medical Laboratory) and co-organized by the Shenzhen Analysis and Testing Association. It focused on TCM quality improvement, modern analytical technologies, artificial intelligence applications, and innovative R&D. Nearly 100 representatives from drug regulation, inspection and testing, research institutions, and TCM manufacturers attended.
Kenneth To, Senior Manager of the Food and Pharmaceutical Division at CMA Testing, was invited to share the new Hong Kong proprietary Chinese medicine registration rules and the classification and triage mechanism. Combining registration requirements with the classification and triage logic, he explained documentation preparation, pathway selection, and compliance points, helping companies better understand Hong Kong market access rules. During on-site discussions, how testing and certification can connect with registration compliance and help products “go global” became a key focus for participating companies.
CMA Testing will continue to leverage its professional strengths in third-party testing and certification, build a bridge for information exchange between the mainland and Hong Kong, promote the integration of TCM quality management with modern analytical testing technologies, and support the digital and intelligent transformation and steady overseas expansion of the TCM industry.
